Search Results 951-960 of 16343 for pharmacogenetics
The objectives of this study are to create a proteomic profile (Host Response) using plasma from patients before and after anti-cancer therapy, and to associate ...
Advancing treatments for acute myeloid leukemiaDecember 20, 2022 Acute myeloid leukemia (AML), also called acute myelogenous leukemia, is a cancer of the blood ...
Video: A healthy liver transitions to cirrhosis, illustrating a potential outcome of metabolic dysfunction-associated steatotic liver disease — formerly ...
Study is a double-blind, randomized, placebo controlled, dose escalating study. The primary objective of this study is to evaluate the safety, tolerability and ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers. ROCHESTER, ...
At the first U.S. 'Undiagnosed Hackathon,' scientists from around the world will team up at Mayo Clinic to solve unsolved medical mysteries. Young Julian Limon[ ...
The purpose of this study is to identify new mechanisms responsible for age related impairment in bone formation by studying specific genes and pathways related ...
Researchers are leading the nation in developing powerful and precise radiopharmaceutical theranostics intended to treat people with deadly cancers.
Hemophilia. These services are provided through the Mayo Clinic Special Coagulation Laboratories, the Coagulation Clinic and Coagulation Consulting Group, and ...
The purpose of this study is to compare a limited magnetic resonance enterography (MREN) to routine MREN in order to determine non-inferiority, missed findings, ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.